Jerzy Pieczykolan Selected Research

CPL207280

10/2021

CPL207280, a Novel G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1-Specific Agonist, Shows a Favorable Safety Profile and Exerts Antidiabetic Effects in Type 2 Diabetic Animals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerzy Pieczykolan Research Topics

Disease

5	Neoplasms (Cancer) 05/2022 - 02/2017
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 10/2021
2	Hypoglycemia (Reactive Hypoglycemia) 12/2021 - 10/2021
1	Neoplasm Metastasis (Metastasis) 05/2022
1	Treatment-Resistant Depressive Disorder 01/2022
1	Catalepsy 11/2021
1	Parkinson Disease (Parkinson's Disease) 11/2021
1	Animal Disease Models 10/2021
1	Chemical and Drug Induced Liver Injury 01/2021
1	Asthma (Bronchial Asthma) 01/2020
1	Cognitive Dysfunction 10/2019

Drug/Important Bio-Agent (IBA)

2	TAK-875IBA 10/2021 - 01/2021
2	auristatinIBA 11/2018 - 02/2017
1	c-Mer Tyrosine KinaseIBA 05/2022
1	Ketamine FDA LinkGeneric 01/2022
1	EsketamineIBA 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 12/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 11/2021
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	CPL207280IBA 10/2021
1	Dihydrotachysterol (AT 10)IBA 10/2021
1	Peptides (Polypeptides)IBA 01/2020
1	PowdersIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	naphthaleneIBA 10/2019
1	AminesIBA 10/2019
1	Scopolamine (Hyoscine)FDA Link 10/2019
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2018
1	CytokinesIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 02/2017

Therapy/Procedure

3	Therapeutics 05/2022 - 02/2017
1	Glycemic Control 10/2021